tiprankstipranks

E. Roudasev Profile - Seeking Alpha Blogger

4 Followers
tipranks
E. Roudasev

E. Roudasev
Seeking Alpha

Financial Blogger
#18,628 out of 30,170 Financial Bloggers
#26,576 out of 39,344 experts

Success Rate

33%
10 out of 30 ratings made a profit

Average Return

-7.90%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying E. Roudasev's trades since 2022 and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -7.9% per rating.

Stock Rating Distribution

31Ratings
90.32% Bullish
6.45% Bearish
3.23% Neutral
Distribution of E. Roudasev's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
CanadaCanadian Market

Best Rating

Stock:
Biovie Inc.
(BIVI)
Rating:Buy
Date:Jun 07, 2022 - Jun 07, 2023
Return:+217.50%
The most profitable rating made by E. Roudasev

E. Roudasev's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
Nkarta
May 20, 2022
Bullish
1Ratings
0%
-64.00%
Cardiff Oncology
Jun 07, 2022
Bullish
1Ratings
100%
+2.90%
CYADY
Celyad Oncology
Jul 19, 2022
Bullish
1Ratings
0%
-64.20%
Kodiak Sciences
Aug 08, 2022
Bullish
1Ratings
0%
-72.90%
TCRR
TCR2 Therapeutics
Aug 18, 2022
Bullish
1Ratings
0%
-55.50%
HARP
Harpoon Therapeutics
Sep 01, 2022
Bullish
1Ratings
0%
-43.70%
Soligenix
Oct 05, 2022
Bullish
1Ratings
0%
-93.00%
Athira Pharma
Oct 20, 2022
Bullish
2Ratings
50%
-23.85%
Inmune Bio
Jan 05, 2023
Bullish
1Ratings
100%
+79.10%
BriaCell Therapeutics
Jan 30, 2023
Bullish
1Ratings
0%
-40.80%
List of latest recommendations made by E. Roudasev. Click to expand and see E. Roudasev's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.